Igor Kozak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Igor Kozak has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
William R. Freeman
Department of Ophthalmology, University of California San Diego, Jacobs Retina Center at Shiley Eye Center, La Jolla, California
3 shared publicationsDirk-Uwe Bartsch
Joan and Irwin Jacobs Retina Center at the Shiley Eye Center, La Jolla, CA, USA
2 shared publicationsAlka Ahuja
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
1 shared publicationAnthony J Bron
1 shared publicationChris W Heichel
1 shared publication- Christopher H. Woelk
Faculty of Medicine, University of Southampton, Southampton, Hants, United Kingdom
1 shared publication
Latest Publications
- 7 August 2012
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 251 (4) , 1049-1053
Time required for navigated macular laser photocoagulation treatment with the Navilas®
Navilas® laser is a novel technology combining photocoagulation with imaging, including fluorescein angiographic (FA) images which are annotated and aligned to a live fundus view. We determine the time necessary for planning and treatment of macular edema utilizing the Navilas®. The screen recordings during treatments were retrospectively analyzed for treatment type, number of laser shots, the duration of planning (measured from the time the planning image was selected to time of marking the last planned treatment spot), and total time of laser application. A total of 93 treatments (30 grid, 30 focal and 33 combined treatments) by four physicians from three sites were included. An average of 125 spots were applied to each eye. The total time spent for each focal treatment - including the planning was 7 min 47 s (±3 min and 32 s). Navilas® is a novel device providing a time efficient platform for evaluating FA images and performing threshold macular laser photocoagulation.
- 7 August 2012
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 251 (4) , 1049-1053
Time required for navigated macular laser photocoagulation treatment with the Navilas®
Navilas® laser is a novel technology combining photocoagulation with imaging, including fluorescein angiographic (FA) images which are annotated and aligned to a live fundus view. We determine the time necessary for planning and treatment of macular edema utilizing the Navilas®. The screen recordings during treatments were retrospectively analyzed for treatment type, number of laser shots, the duration of planning (measured from the time the planning image was selected to time of marking the last planned treatment spot), and total time of laser application. A total of 93 treatments (30 grid, 30 focal and 33 combined treatments) by four physicians from three sites were included. An average of 125 spots were applied to each eye. The total time spent for each focal treatment - including the planning was 7 min 47 s (±3 min and 32 s). Navilas® is a novel device providing a time efficient platform for evaluating FA images and performing threshold macular laser photocoagulation.
- 14 June 2012
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 20 (5) , 342-348
Optic Nerve Head Morphology and Visual Field Function in Patients with AIDS and without Infectious Retinitis
Purpose: To evaluate morphology of the optic nerve head and visual field in AIDS patients without retinitis. Methods: One randomly selected eye from 246 patients with AIDS without retinitis was evaluated from prospective multicenter Longitudinal Studies of Ocular Complications of AIDS. Stereo fundus photographs of OHN and serial VF data over 5-years were analyzed. Main outcomes included vertical cup-to-disc ratio (CDR), mean deviation, and pattern standard deviation scores on VF testing. Results: The median CDR was 0.39 at enrollment and 0.40 at 5-year follow-up. An unadjusted linear regression model revealed a mean change in CDR of 0.004 after 5-years (P = 0.04). After adjustment for practice effect, there were no statistically significant changes in VF performance observed during the 5 years of follow-up. Conclusions: We detected clinically minimal, but statistically significant changes in ONH morphology and no change in VF performance among eyes of patients with AIDS and without retinitis.
- 14 June 2012
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 20 (5) , 342-348
Optic Nerve Head Morphology and Visual Field Function in Patients with AIDS and without Infectious Retinitis
Purpose: To evaluate morphology of the optic nerve head and visual field in AIDS patients without retinitis. Methods: One randomly selected eye from 246 patients with AIDS without retinitis was evaluated from prospective multicenter Longitudinal Studies of Ocular Complications of AIDS. Stereo fundus photographs of OHN and serial VF data over 5-years were analyzed. Main outcomes included vertical cup-to-disc ratio (CDR), mean deviation, and pattern standard deviation scores on VF testing. Results: The median CDR was 0.39 at enrollment and 0.40 at 5-year follow-up. An unadjusted linear regression model revealed a mean change in CDR of 0.004 after 5-years (P = 0.04). After adjustment for practice effect, there were no statistically significant changes in VF performance observed during the 5 years of follow-up. Conclusions: We detected clinically minimal, but statistically significant changes in ONH morphology and no change in VF performance among eyes of patients with AIDS and without retinitis.
- 6 July 2011
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 249 (11) , 1643-1647
Relationship between retinal nerve fiber layer thickness and driving ability in patients with human immunodeficiency virus infection
The aim of this work is to study the possible association between retinal nerve fiber layer (NFL) thickness and driving ability.
- 6 July 2011
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 249 (11) , 1643-1647
Relationship between retinal nerve fiber layer thickness and driving ability in patients with human immunodeficiency virus infection
The aim of this work is to study the possible association between retinal nerve fiber layer (NFL) thickness and driving ability.
- 1 October 2010
- Published by Wolters Kluwer Health in Retina
- Vol. 30 (9) , 1556
Reply
- 1 March 2010
- Published by Wolters Kluwer Health in Retina
- Vol. 30 (3) , 431-435
OPTICAL COHERENCE TOMOGRAPHY-RASTER SCANNING AND MANUAL SEGMENTATION IN DETERMINING DRUSEN VOLUME IN AGE-RELATED MACULAR DEGENERATION
Purpose: Drusen are the hallmark of age-related macular degeneration (AMD), and substantial evidence exists that the amount of drusen and their effect on retinal pigment epithelium is a strong predictor of progression of AMD and vision loss. Until recently, it was not possible to quantitate the volume of the drusen. However, the use of image-stabilized scanning laser ophthalmoscope or spectral domain-optical coherence tomography (OCT) has enabled determination of drusen volume of this abnormal material. The purpose of this study was to assess the correlation of drusen volume with Age-Related Eye Disease Study (AREDS) grade and drusen area in dry AMD. Methods: Thirty-six eyes from 18 patients with nonexudative AMD with visual acuity between 20/16 and 20/160 were studied. Spectral domain-OCT or simultaneous OCT scans were taken as color fundus photographs (35°) of each eye. Early Treatment Diabetic Retinopathy Study visions were also recorded. The full AREDS score excluding late-stage AMD was determined by agreement between two trained observers. Drusen volume was determined by examination of a series of 96 spectral domain-OCT scans taken from arcade to arcade for a length of 6 mm. The volume was determined by calculating the drusen area in each scan and determining the drusen volume by calculating the effective volume of each cut using National Institutes of Health Image J. Drusen were identified and outlined manually, not using an automated algorithm. Results: There was a strong and significant correlation between drusen volume and AREDS-determined drusen area (P < 0.0001, r = 0.78). In addition, there was a correlation between AREDS classification and drusen volume (P = 0.023, r = 0.43) as determined by pairwise correlation. Conclusion: Drusen volume as determined by spectral domain-OCT correlates with AREDS-determined drusen area and AREDS grade in nonexudative AMD. The correlation is not perfect, however, because drusen area and volume average 40% and 82% of the variation, respectively. Drusen volume can provide additional information in grading the severity of eyes with dry AMD.
- 1 March 2010
- Published by Wolters Kluwer Health in Retina
- Vol. 30 (3) , 431-435
OPTICAL COHERENCE TOMOGRAPHY-RASTER SCANNING AND MANUAL SEGMENTATION IN DETERMINING DRUSEN VOLUME IN AGE-RELATED MACULAR DEGENERATION
Purpose: Drusen are the hallmark of age-related macular degeneration (AMD), and substantial evidence exists that the amount of drusen and their effect on retinal pigment epithelium is a strong predictor of progression of AMD and vision loss. Until recently, it was not possible to quantitate the volume of the drusen. However, the use of image-stabilized scanning laser ophthalmoscope or spectral domain-optical coherence tomography (OCT) has enabled determination of drusen volume of this abnormal material. The purpose of this study was to assess the correlation of drusen volume with Age-Related Eye Disease Study (AREDS) grade and drusen area in dry AMD. Methods: Thirty-six eyes from 18 patients with nonexudative AMD with visual acuity between 20/16 and 20/160 were studied. Spectral domain-OCT or simultaneous OCT scans were taken as color fundus photographs (35°) of each eye. Early Treatment Diabetic Retinopathy Study visions were also recorded. The full AREDS score excluding late-stage AMD was determined by agreement between two trained observers. Drusen volume was determined by examination of a series of 96 spectral domain-OCT scans taken from arcade to arcade for a length of 6 mm. The volume was determined by calculating the drusen area in each scan and determining the drusen volume by calculating the effective volume of each cut using National Institutes of Health Image J. Drusen were identified and outlined manually, not using an automated algorithm. Results: There was a strong and significant correlation between drusen volume and AREDS-determined drusen area (P < 0.0001, r = 0.78). In addition, there was a correlation between AREDS classification and drusen volume (P = 0.023, r = 0.43) as determined by pairwise correlation. Conclusion: Drusen volume as determined by spectral domain-OCT correlates with AREDS-determined drusen area and AREDS grade in nonexudative AMD. The correlation is not perfect, however, because drusen area and volume average 40% and 82% of the variation, respectively. Drusen volume can provide additional information in grading the severity of eyes with dry AMD.
- 1 January 2010
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 4 (2) , 146-149
NEW RETINAL FINDINGS IN CHERUBISM
Purpose: To report three new retinal findings in a patient with cherubism. Participant: An 18-year-old male patient. Methods: Clinical examination and retinal scanning with spectral domain optical coherence tomography. Results: The spectral domain optical coherence tomography revealed inner retinal striae in the posterior pole of both eyes and a subfoveal vitelliform deposit in the left eye. There was an inferior retinoschisis in the left eye. Conclusions: The inner retinal striae, subretinal vitelliform deposit, and retinoschisis extend the scale of retinal findings associated with orbital (facial) cherubism.
- 1 January 2010
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 4 (2) , 146-149
NEW RETINAL FINDINGS IN CHERUBISM
Purpose: To report three new retinal findings in a patient with cherubism. Participant: An 18-year-old male patient. Methods: Clinical examination and retinal scanning with spectral domain optical coherence tomography. Results: The spectral domain optical coherence tomography revealed inner retinal striae in the posterior pole of both eyes and a subfoveal vitelliform deposit in the left eye. There was an inferior retinoschisis in the left eye. Conclusions: The inner retinal striae, subretinal vitelliform deposit, and retinoschisis extend the scale of retinal findings associated with orbital (facial) cherubism.
- 1 June 2007
- Published by Wolters Kluwer Health in Cornea
- Vol. 26 (5) , 610-614
Morphologic and Volumetric Studies of the Meibomian Glands in Elderly Human Eyelids
To study the microscopic structure of postmortem human Meibomian glands (MGs) in the elderly. Human MG samples from left lower eyelids were obtained at autopsy from 5 men and 4 women with a mean age of 63.1 +/- 7.67 years. The tissues were fixed and embedded in paraffin. Serial transverse sections 5 mum thick were stained with hematoxylin and eosin (H&E), van Gieson, and Masson blue stains. Computer-assisted 3-dimensional reconstructions of MGs were performed, and morphologic and volumetric data were analyzed. The average length of human MGs in the nasal, central, and temporal areas was 1.551 +/- 0.43, 1.654 +/- 0.47, and 1.594 +/- 0.57 mm, respectively. The average surface area of the glands in the nasal, central, and temporal areas was 0.029 +/- 0.03, 0.033 +/- 0.01, and 0.056 +/- 0.03 mm, respectively. The average volume of glands in the nasal, central, and temporal areas was 0.054 +/- 00.4, 0.056 +/- 0.03, and 0.053 +/- 0.03 mm, respectively. A circular, floral arrangement of acini, surrounding the terminal duct just deep to the skin, is probably responsible for the circular arrangement seen clinically around each healthy orifice. We confirmed that most glands are embedded within a cylindrical, connective tissue matrix. We report the dimensions of normal Meibomian acini in an older population. Some structural features observed may explain normal physiologic landmarks or contribute to glandular pathophysiology.
- 1 June 2007
- Published by Wolters Kluwer Health in Cornea
- Vol. 26 (5) , 610-614
Morphologic and Volumetric Studies of the Meibomian Glands in Elderly Human Eyelids
To study the microscopic structure of postmortem human Meibomian glands (MGs) in the elderly. Human MG samples from left lower eyelids were obtained at autopsy from 5 men and 4 women with a mean age of 63.1 +/- 7.67 years. The tissues were fixed and embedded in paraffin. Serial transverse sections 5 mum thick were stained with hematoxylin and eosin (H&E), van Gieson, and Masson blue stains. Computer-assisted 3-dimensional reconstructions of MGs were performed, and morphologic and volumetric data were analyzed. The average length of human MGs in the nasal, central, and temporal areas was 1.551 +/- 0.43, 1.654 +/- 0.47, and 1.594 +/- 0.57 mm, respectively. The average surface area of the glands in the nasal, central, and temporal areas was 0.029 +/- 0.03, 0.033 +/- 0.01, and 0.056 +/- 0.03 mm, respectively. The average volume of glands in the nasal, central, and temporal areas was 0.054 +/- 00.4, 0.056 +/- 0.03, and 0.053 +/- 0.03 mm, respectively. A circular, floral arrangement of acini, surrounding the terminal duct just deep to the skin, is probably responsible for the circular arrangement seen clinically around each healthy orifice. We confirmed that most glands are embedded within a cylindrical, connective tissue matrix. We report the dimensions of normal Meibomian acini in an older population. Some structural features observed may explain normal physiologic landmarks or contribute to glandular pathophysiology.
- 1 September 2006
- Published by BMJ in British Journal of Ophthalmology
- Vol. 90 (9) , 1152-1156
Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration
To investigate the safety and effectiveness of extrafoveal photodynamic therapy (PDT) occlusion of feeder vessels (FVs) in patients with subfoveal choroidal neovascularisation (CNV) as a result of age related macular degeneration. FVs were identified using dynamic fluorescein and indocyanine green angiography with scanning laser ophthalmoscope. The standard doses of verteporfin and laser wavelength were used. The light dose was escalated by increasing the duration of the light dose so the light regimen was 50 J/cm2 for patients 1 and 2; 100 J/cm2 for patients 3, 4, 5; 125 J/cm2 for patients 6 and 7; and 150 J/cm2 for patients 8 and 9. Patients were examined at weeks 1, 4, and 12. The mean improvement on EDTRS chart 3 months after treatment was an increase of 2.1 lines (p = 0.07). Closure of the FV was achieved angiographically in three eyes at various light doses, in three eyes the FV was hypoperfused, and in three eyes the vessels were were neither closed nor hypoperfused. At the last follow up all FVs were reperfused. There was no evidence of retinal damage. Verteporfin enhanced FV therapy does not cause subfoveal retinal damage and may have potential to improve central vision in subfoveal CNV caused by exudative macular degeneration. It is not recommended as a monotherapy for CNV.
- 1 September 2006
- Published by BMJ in British Journal of Ophthalmology
- Vol. 90 (9) , 1152-1156
Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration
To investigate the safety and effectiveness of extrafoveal photodynamic therapy (PDT) occlusion of feeder vessels (FVs) in patients with subfoveal choroidal neovascularisation (CNV) as a result of age related macular degeneration. FVs were identified using dynamic fluorescein and indocyanine green angiography with scanning laser ophthalmoscope. The standard doses of verteporfin and laser wavelength were used. The light dose was escalated by increasing the duration of the light dose so the light regimen was 50 J/cm2 for patients 1 and 2; 100 J/cm2 for patients 3, 4, 5; 125 J/cm2 for patients 6 and 7; and 150 J/cm2 for patients 8 and 9. Patients were examined at weeks 1, 4, and 12. The mean improvement on EDTRS chart 3 months after treatment was an increase of 2.1 lines (p = 0.07). Closure of the FV was achieved angiographically in three eyes at various light doses, in three eyes the FV was hypoperfused, and in three eyes the vessels were were neither closed nor hypoperfused. At the last follow up all FVs were reperfused. There was no evidence of retinal damage. Verteporfin enhanced FV therapy does not cause subfoveal retinal damage and may have potential to improve central vision in subfoveal CNV caused by exudative macular degeneration. It is not recommended as a monotherapy for CNV.